VREX Earnings Prediction
The chart below shows how VREX performed 10 days before and after its earnings report, based on data from the past quarters. Typically, VREX sees a -1.08% change in stock price 10 days leading up to the earnings, and a -4.97% change 10 days following the report. On the earnings day itself, the stock moves by +0.39%. This data can give you a slight idea of what to expect for the next quarter's release.
VREX Key Earning Data
2024/Q4
Year Over Year
Quarter Over Quarter
Total Revenue
199.80M
5.16%
-2.87%
Gross Margin
34.28%
14.08%
5.09%
Operating Margin
5.61%
153.85%
5.85%
Net Margin
-0.05%
-76.19%
-99.79%
EPS
-0.01
-0.00%
-99.18%
No Data Available
VREX Earnings Analysis
Varex Imaging Corp Corporation (VREX.O) Earnings Conference Call
Positive
Earnings Beat Expectations: Varex Imaging Corporation reported a non-GAAP EPS of $0.07, exceeding expectations of $0.04, indicating strong financial performance in Q1 2025.
Quarterly Revenue Increase: Total revenue for the first quarter increased by 5% year over year, driven by a 3% increase in the medical segment and a 10% increase in the industrial segment.
Gross Margin Improvement: Non-GAAP gross margin improved to 35%, up from 31% in the same quarter last year, reflecting a favorable product sales mix and productivity gains.
Strong Cash Flow: Cash from operations was solid at $10 million for the quarter, supported by effective working capital management, contributing to a cash balance of $219 million, up $24 million year over year.
Strong Operational Efficiency: Adjusted EBITDA for the quarter was $24 million, representing 12% of sales, with a trailing twelve months adjusted EBITDA of $94 million, showcasing strong operational efficiency.
Negative
Q1 Revenue Shortfall: Revenue in the first quarter was $200 million, which was below the midpoint of guidance, indicating a shortfall in expected sales performance.
EMEA Revenue Decline: EMEA revenues decreased by 9% compared to the first quarter of fiscal 2024, highlighting a significant decline in this key market.
Operating Expenses Concern: Operating expenses increased by $4 million to $57 million compared to the first quarter of fiscal 2024, raising concerns about cost management amidst revenue growth.
Quarterly Net Loss Analysis: Net loss for the quarter was $264,000, translating to a GAAP EPS loss of $0.01 per share, indicating financial strain despite positive non-GAAP results.
Inventory Management Inefficiencies: Days of inventory increased by 35 days to 209 days, suggesting potential inefficiencies in inventory management and a buildup of unsold products.
VREX FAQs
How does VREX typically perform around its earnings report dates?
Is Varex Imaging Corp (VREX) Q1 2025 Earnings Call Summary positive or negative?
How can historical earnings data help predict future stock performance?
VREX Earning Call Sentiment
Varex Imaging Corporation (NASDAQ:VREX) Q1 2025 Earnings Call Transcript
VREX.O
0.71%Positive
The earnings call reveals mixed signals: positive financial performance with revenue growth, improved margins, and cash flow, but offset by uncertainties in Chinese market impact and supply chain issues. The Q&A highlights management's cautious outlook on China and supply challenges. The lack of a share repurchase program and unclear responses about Chinese stimulus also suggest caution. Overall, these factors indicate a neutral sentiment, with no strong catalysts for significant stock movement.
